DEC 06, 2017 3:17 PM PST

Common Hypertension Drug Could Up Skin Cancer Risks by 7-Fold

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

One of the most common drugs taken for high blood pressure could be raising the risk of skin cancers by seven times, according to a new report.

As a high blood pressure (hypertension) drug, hydrochlorothiazide (HCTZ) is a diuretic. In essence, HCTZ promotes the increased production of urine, thereby relieving water retention and high blood pressure. The drug became commercially available in 1959, and is on the World Health Organization’s List of Essential Medicines. Now, the drug is one of the most ubiquitously prescribed medications for hypertension – in the US alone, HCTZ was the second most commonly used drugs for hypertension in 2008.  

Known side effects of HCTZ include electrolyte imbalances and poor kidney functions. But the drug could have a darker impact on the health of patients.

Based on previous research that cite a link between HCTZ and lip cancer, researchers from the University of Southern Denmark in Odense, began digging deeper. They formally tested the hypothesis in a large sample, consisting of over 80,000 patients with skin cancer and 1.5 million healthy patients. In both groups, the team analyzed HCTZ use, as well as use of any other high blood pressure medications.

Based on their analysis, the team reported that people who regularly take HCTZ had more than seven times the likelihood of developing skin cancer. Importantly, the risks were increased for squamous cell carcinoma and basal cell carcinoma, two types of skin cancer that are less aggressive than melanoma.
 

The results support other findings that show HCTZ can make the skin more prone to ultraviolet radiation damage.

"We knew that hydrochlorothiazide made the skin more vulnerable to damage from the sun's UV rays, but what is new and also surprising is that long-term use of this blood pressure medicine leads to such a significant increase in the risk of skin cancer," said Anton Pottegård, an associate professor of clinical pharmacology at the University of Southern Denmark, and the study’s senior author.

This finding could have big ramifications for the use of HCTZ for patients living in intensely sunny parts of the world, such as Florida. "The combination of living and residing in sunny Florida while taking hydrochlorothiazide seems to be very serious and even life-threatening for some patients," said Dr. Armand Cognetta, chief division of dermatology at Florida State University in Tallahassee and the study’s co-author.

"We have seen and followed many patients with different skin cancers where the only risk factor apart from exposure to sunlight seems to be hydrochlorothiazide," he added.

But as with any medications, the benefits and side effects must be carefully considered for every individual. "The risk of skin cancer must, of course, be weighed against the fact that hydrochlorothiazide is an effective and otherwise safe treatment for most patients,” said Pottegård. In short, patients on HCTZ should talk to their doctor before making any adjustments to their treatment regimen.

"Nevertheless our results should lead to a reconsideration of the use of hydrochlorothiazide. Hopefully, with this study, we can contribute towards ensuring safer treatment of high blood pressure in the future,” he said.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 27, 2020
Cell & Molecular Biology
UVC Rays May be a Bigger Cancer Risk Than Known
NOV 27, 2020
UVC Rays May be a Bigger Cancer Risk Than Known
The sun emits different kinds of light and rays including visible and ultraviolet (UV) and infrared. Some of those forms ...
DEC 23, 2020
Cancer
Using AI to identify new measures of mammography
DEC 23, 2020
Using AI to identify new measures of mammography
New findings published in the International Journal of Cancer from the University of Melbourne report that new mamm ...
JAN 19, 2021
Cancer
Report on alcohol-related cancer incidence and mortality by state
JAN 19, 2021
Report on alcohol-related cancer incidence and mortality by state
New research published in Cancer Epidemiology suggests that alcohol consumption is associated with cancer incidence and ...
JAN 25, 2021
Cancer
Combining Radiotherapy and Immunotherapy in Liver Cancer
JAN 25, 2021
Combining Radiotherapy and Immunotherapy in Liver Cancer
The dream of a magic bullet drug plagues the mind of scientists, doctors, and patients. The truth is some diseases are j ...
FEB 02, 2021
Immunology
Pumping the Brakes on Stomach Cancer Progression
FEB 02, 2021
Pumping the Brakes on Stomach Cancer Progression
By the time stomach cancer is diagnosed, it’s often bad news for patients. The disease often presents with relativ ...
FEB 10, 2021
Drug Discovery & Development
Genetics Affect Response to Cancer Immunotherapy
FEB 10, 2021
Genetics Affect Response to Cancer Immunotherapy
Researchers have found that genetic factors may dictate as much as 20% of the efficacy of checkpoint inhibitors, a kind ...
Loading Comments...